17.06.2020 – 15:12
OPTIMA is supplying vial filling line for COVID-19 vaccine program
Optima Group welcomes Catalent’s recent announcement that it has signed an agreement with a major global pharmaceutical company to accelerate availability of manufacturing capacity and prepare for large-scale commercial manufacturing of a lead vaccine candidate for COVID-19 at Catalent’s facility in Bloomington, Indiana. Scale-up in production will include the use of an Optima high-speed vial filling line.
The complete press release and images can be found in the download area below. We are looking forward to a publication.
OPTIMA packaging group GmbH
+49 (0)791 / 506-1472
Editor: OPTIMA packaging group GmbH Managing Directors: Hans Bühler, Dr. Jürgen Kuske Commercial Register: Stuttgart: HRB 571090 VAT Id.no.: DE 145 209 170 Tax No. 84060/09756
Further material to download document: 2020-06-16 I Press r~cine program(P.DOCX